Warrant Exercise Notice and Total Voting Rights
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
SkinBioTherapeutics plc, (AIM: SBTX, or the "Company"), the life science business focused on skin health, announces that it received an Exercise Notice from Macquarie ("Macquarie") for 1,000,000 ordinary shares in SkinBioTherapeutics plc at £0.2043 per share.
Following the above exercise, the remaining warrants outstanding with Macquarie are 1,099,244 warrants.
Admission and Total Voting Rights
Application has been made for the 1,000,000 new ordinary shares, which will rank pari passu in all respects with the existing ordinary shares of the Company, to be admitted to AIM, which is expected to occur on or around 8.00 a.m. on 8 April 2025 ("Admission"). Upon Admission, the total number of issued shares and the total number of voting rights in the Company will be 232,975,383.
The above figure of 232,975,383 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
596/2014.
Caution regarding forward looking statements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.